News
AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...
Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback